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PENILAIAN KOGNITIF DAN NEUROPSIKOLOGIKAL DALAM 
KALANGAN PESAKIT YANG ADA DWI-KEBERGANTUNGAN 
TERHADAP OPIOID DAN PERANGSANG JENIS AMFETAMINA (COATS) 
 
ABSTRAK 
Kajian menunjukkan individu yang ada kebergantungan terhadap dadah 
mempunyai fungsi kognitif yang lebih rendah dalam domain fungsi eksekutif. Kajian 
yang melibatkan pengguna dadah yang menggunakan beberapa jenis dadah adalah 
terhad. Kajian ini direka bentuk untuk menilai skop dan corak spesifik masalah 
kefungsian kognitif dan neuropsikologikal dalam kalangan individu yang 
menyalahgunakan  opioid dan ATS (dwi-kebergantungan (DDD)) dan memasuki 
rawatan bantuan ubatan di Hospital Universiti Sains Malaysia (HUSM), Kelantan. 
Sejumlah n=96 responden lelaki (n=56 pesakit dan n=40 kumpulan kawalan) telah 
diambil untuk kajian rentas ini. Ujian neuropsikologikal Rey Osterrieth Complex 
Figure, Trail Making Test, Raven’s Progressive Matrices, Digit Span Test, Digit 
Symbol Test, and Stroop Test telah dilakukan. Keputusan kajian menunjukkan prestasi 
pesakit adalah lebih rendah daripada prestasi kumpulan kawalan dalam kelajuan 
persepsi motor dan imbasan visual yang diukur menggunakan Trail Making Test Part 
A, dalam fleksibiliti kognitif yang diukur menggunakan Trail Making Test Part B dan 
dalam kelajuan pemprosesan mental yang diukur menggunakan Digit Symbol Test. 
Keputusan menunjukkan ada sedikit gangguan dalam kelajuan persepsi motor, imbasan 
visual, fleksibiliti kognitif dan kelajuan pemprosesan mental dalam kalangan pesakit 
yang ada dwi-kebergantungan. Oleh itu, intervensi pencegahan dan rawatan  yang baik 
perlu mengambil kira masalah kognitif dalam kalangan pesakit yang ada dwi-
kebergantungan. 
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COGNITIVE AND NEUROPSYCHOLOGICAL ASSESSMENTS 
AMONG CO-OCCURRING OPIOID AND AMPHETAMINE-TYPE 
STIMULANT (COATS) DEPENDENT PATIENTS 
 
ABSTRACT 
Several studies have shown that individuals with drug dependence have poorer 
cognitive functions in the domain of executive functions. Studies investigating 
cognitive impairments in people with poly-drug use are limited. This study is designed 
to evaluate the scope and the specific patterns of deficits in cognitive and 
neuropsychological functioning among opiate and ATS (Dual Drug Dependence 
(DDD)) abusing individuals enrolled in a medication-assisted treatment in Hospital 
Universiti Sains Malaysia (HUSM), Kelantan. A total of n=96 male respondents (n=56 
patients, and n=40 control group) were recruited for this cross-sectional study. 
Cognitive functions evaluated were Rey-Osterrieth Complex Figure, Trail Making 
Test, Raven’s Progressive Matrices, Digit Span Test, Digit Symbol Test, and Stroop 
Test were administered. Results showed that patients performed significantly worse in 
perceptual motor speed and visual scanning measured by Trail Making Test Part A, 
cognitive flexibility measured by Trail Making Test Part B, and mental processing 
speed measured by Digit Symbol Test compared to those in the control group. Results 
suggest that there were slight impairments in perceptual motor speed, visual scanning, 
cognitive flexibility, and mental processing speed among patients with dual drug 
dependence. Therefore, proper prevention and treatment interventions should take into 
account the cognitive problems in patients who have dual dependency. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background Of The Study 
Drug addiction continues to be a global rampant problem. According to 
National Institute of Drug Abuse (2014), addiction is a relapsing disease characterized 
by intense drug seeking behavior and use of drug accompanied by chemical changes in 
brain Malaysia is also no exception in this problem. In Malaysia, heroin continues to 
be the main drug used whereas amphetamine-type stimulants use is increasing (Singh, 
Chawarski, Schottenfeld, & Vicknasingam, 2013). The drug users that were detected 
between 1988 and 2006 were 300,241. It is also estimated that Malaysia has 170,000 
injecting drug users who also have Human Immunodeficiency Virus (HIV) and the 
prevalence among drug users in the country ranges from 25% to 45% (Singh et al., 
2013). 
Recently, amphetamine-type stimulants (ATS), including crystal 
methamphetamine and various other methamphetamine and/or amphetamine-
containing substances/pills, have been identified as a growing problem, not only in 
Malaysia but also throughout the Southeast Asia Region (Mcketin, Kozel, & Douglas, 
2008). Although much research has been done on drug addiction in Malaysia, the 
cognitive and neuropsychological aspects of drug use remained scarce (Zamani, Nasir, 
Desa, Khairudin, & Yusooff, 2014). 
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1.2 Opioid 
Opioid is usually used in medicine for pain relief. But misuse of opioid may 
lead to many withdrawal symptoms such as restlessness, weakness, chills, body and 
joint pain, social withdrawal and many more. There has been little study on 
neurocognitive effects by heroin pure users. Opioids, namely heroin and illicit 
morphine, continued to be the most widely used drugs in Malaysia (United Nation 
Office on Drugs and Crime, 2013). Heroin remains the primary drug used in Malaysia. 
In 2012, approximately 48% of all drug users had used heroin while 31% had used illicit 
morphine (Malaysia Country Report, 2013).  A large portion of heroin seized in 
Malaysia is originated from Myanmar and is trafficked overland through Thailand 
(Malaysia Country Report, 2013). Malaysia has been involved in drug abuse problems 
since the 1970s, and the major driver of HIV transmission in Malaysia is causing by 
drug abuse (Chawarski, Vicknasingam, Mazlan, & Schottenfeld, 2012). 
Heroin is extracted from the poppy plant. It is characterized as a white powder 
with a bitter taste. Pure heroin can be either smoked or inhaled. The short term effect 
of heroin is being in a pleasurable sensation due to the activation of brain reward system 
and this may last for a few hours, thus, individual must take it repeatedly and lead to 
addiction (National Institute of Drug Abuse, 2010). Long term effect and repeated use 
of heroin can change physiology and neuronal imbalance in brain and aid to physical 
dependence on this drug (NIDA, 2014) 
Withdrawal symptoms such as muscle pain, insomnia, restlessness, bone pain, 
and many more occur when one stops using heroin. Addiction to heroin may bring the 
individual to put the use of this drug are main purpose of life. But, there are several 
medications that are recommended for detoxification from heroin such as Methadone 
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and Buprenorphine (Whelan & Remski, 2012). Also, some cognitive behavioral 
therapies (CBT) are recommended as part of treatment. CBT is the process of 
identifying negative pattern of thought which will influence one’s behavior. The 
negative thought patterns always play a main role in development of addiction 
(Kimmel, 2015). Examples of CBT techniques used in addiction treatment include 
pleasant activity schedule which may help recovering addict to make a healthy weekly 
list including fun activities that may break up daily routines. This may help reduce 
negative automatic thoughts and the subsequent need to use drug. (Addiction Center, 
2015). 
 
Figure 1.1: Heroin Powder and Common Route of Administration Using 
Syringe 
1.3 Amphetamine-Type-Stimulants 
Amphetamine and methamphetamine are from the group of psycho-stimulants 
where the methamphetamine is a synthetic derivative of amphetamine. Because of the 
chemical structure of methamphetamine, it has high lipid solubility compared to 
amphetamine and thus, it has intense effect on central nervous system. ATS is a group 
of drugs whose principal members are amphetamine and MA. The use of ATS has 
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become a part of the mainstream culture in many countries and has become a worldwide 
problem in the recent years (United Nation of Drug and Crime, 2009). According to the 
United Nation on Drug and Crime (UNODC), ATS has become the world’s second 
most widely abused drug type after cannabis (UNODC, 2011). The geographical spread 
is widening, but awareness of it is limited. There are urgent needs to study about ATS 
problem because the higher usage may increase the level of presentation of ATS 
psychosis to mental health service (World Health Organization, 2015) 
The trafficking of ATS to Malaysia for both domestic use and as a transit 
location for international markets remains a problem (UNODC, 2013). ATS continued 
to be the most commonly used drug among new drug users and drug users arrested for 
the first time (UNODC, 2013). More recently, ATS including crystal methamphetamine 
and various other methamphetamine and/or amphetamine containing substances or 
pills, have been identified as a growing problem in Malaysia and throughout East and 
South-East Asia (McKetin et al., 2008; Sutcliffe et al., 2009; UNODC, 2011). 
UNODC’s 2010 estimated that up to 20.7 million individuals in Asia and the Pacific 
have used ATS in the past years (Global SMART Programme, 2010). A study done by 
Vicknasingam et al., (2010) found that in many regions of Malaysia, most of opioid 
Injecting Drug Users individuals use ATS during their lifetime.  
Amphetamine also can affect the capacity of brain to stimulate neurogenesis 
(growth and development of nervous tissue) and this could cause the disruption of 
Blood-brain barrier (BBB) (Silva et al., 2010). The chronic effects of amphetamine 
(psychostimulatory effect) not only connected with reward and euphoria, but the effects 
are including impairment in attention and memory. Thus, this cognitive effect related 
to neurotoxic effect of drug and apoptosis (Krasnova, Ladenheim, & Cadet, 2005). 
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Amphetamine in acute phase may inhibit the reuptake of Dopamine, 
Norepinephrine, and Serotonin by membrane transporters and increase this level of this 
neurotransmitter in the brain and it will then result in depletion of dopamine transporter 
and this will give impairment in their neuropsychological functioning (Logan, 2002; 
Camí, & Farré, 2003; Nordahl, Salo, & Leamon, 2003; Fernández-Serrano, Pérez-
Garcia, & Verdejo-Garcia, 2011).  
 
Figure 1.2: ATS tablet that commonly used in Kelantan region 
1.4 Co-Occurring Opioid and Amphetamine Type Stimulants (COATS) 
The use of two or more substances at the same time and sequentially are 
considered as a poly-drug use. There are various patterns that can be seen, one of the 
patterns was different substances being taken together to have a cumulative or 
complementary effect (UNODC, 2014). 
ATS is a stimulant whereas heroin is a depressant. The combination of these 
drugs have become more frequent and popular among drug users (Singh et al., 2013). 
A new trend of dual-dependence (Opioid and ATS) provides the baseline information 
regarding the need to implement the effective treatment approach (Singh et al, 2013). 
The effective treatments include medication therapy and psychological aspect such as 
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counseling. Cognition is the central of drug addiction thus, it is important to conduct 
research that evaluates cognition and one of the tests that can be used to measure it was 
neuropsychological assessment. 
 
The simultaneous use of stimulants and opioids has, for over a century, have 
been reported to be a superior combination for pain relief. Besides, it is perceived that 
the endogenous endorphin-opioid receptor system is the only pain control mechanism 
in the central nervous system. In reality, multiple neurochemical systems are at play in 
pain relief. They include, among others, the serotonergic, gamma-amino-butyric acid 
(GABA-ergenic), and adrenergic (norepinephrine-dopamine) systems. Pain relief with 
stimulants appears to be primarily mediated by norepinephrine and not dopamine. It is 
the simultaneous triggering of the endorphin and adrenergic neurochemical systems 
that gives the combined administration of opioids and stimulants a pain-relieving effect 
much greater than either one alone. 
1.5 Addiction and Cognition 
Cognitive impairment is when a person has trouble remembering, learning new 
things, concentrating, or making decisions that affect their everyday life. Chronic use 
of heroin and morphine may lead to various cognitive impairments (Spain & Newsom, 
1991; Hauser, Houdi, Turbek, Elde, & Ili, 2000; Yin, Woodruff, Zhang, Whaley, Miao, 
& Ferslew, 2006).  The consequence of damaging cognitive function will give the 
negative impact to their thinking and memory process that could lead to mental illness 
and ineffective treatment approach 
There are widespread deficits in neuropsychological function associated with 
chronic use of psychoactive substance (Verdejo-Garcia et al, 2004; Ornstein, Iddon, 
Baldacchino, Sahakian, London, Everitt, & Robbins, 2000).  From the neurological and 
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psychological perspectives, addiction may cause disorders or alteration in cognition. 
Drugs alter normal brain structure and function in regions that are responsible for 
controlling cognitive functions such as learning, attention, memory, and impulse 
control. This will promote continues of drug use and will hinder the treatment process 
that support sustained abstinence. 
Numerous studies found that individuals who use drugs usually have alteration 
in the prefrontal cortex (Kelley, 2004; Kalivas & Volkow, 2005; and Lemoal & Koob, 
2007). There are many factors that influence whether a particular person who takes and 
experiments with opioid drug will continue taking them for a longer time to become 
dependent or addicted. Opioid may provide intense feeling of pleasure. 
Heroin or other opioid can cross the blood brain barrier and thus, travel through 
bloodstream in the brain. The chemical will then be attached to specialized proteins 
called mu receptors on the brain cell. Linkage between this chemical and receptor will 
trigger biochemical brain process and the reward system is activated and they feel 
pleasure. This opioid may activate brain circuit that we call mesolimbic (midbrain) 
reward system. This system then will generate the signal in a part of brain that we call 
ventral tegmental area (VTA) that will result the release of dopamine (DA) in another 
part of brain, the nucleus accumbens (NAc- brain key pleasure centre). The release of 
DA to NAc will cause the feeling of pleasure. The opioid stimulation of brain’s reward 
system is the main reason why some people take drugs repeatedly. Repeated exposure 
of opioid drugs may induce brain mechanism of dependence and lead to daily drug use 
to alleviate withdrawal symptoms.  
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              Figure 1.3: Mesolimbic Reward System (Kosten, & George, 2002) 
1.6 Cognitive Deficit Model 
This model states that a person who develops addictive disorder may have 
abnormalities in an area in brain called the prefrontal cortex (PFC). PFC is important 
for regulation of judgment, planning, and other executive functions. This model also 
proposes that PFC signals to mesolimbic reward system are compromised in individuals 
with addictive disorders and as a result, the ability to use judgments to restrain their 
impulses is reduced and leads to a predisposition to compulsive drug-taking behavior. 
Consistent with this model, stimulant drugs such as ATS is suggested to damage the 
fronto-striatal loop that carries inhibitory signal from PFC to mesolimbic reward 
system. (Kosten & George, 2002) 
1.7 Amphetamine and Opioids Cognitive Deficit 
Both amphetamine and opioid may activate dopamine system in midbrain which 
associated with positive reinforcing effect and have addictive potential. But, both 
pharmacological effects are different. There are studies on comparison of psycho-
stimulant drug and opioids and most of the studies were conducted with participants in 
treatment settings (Fernández-Serrano, Pérez-García & Verdejo-García, 2011). 
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A study performed by Ornstein et al. (2000) that evaluated cognitive functions 
among amphetamine or heroin were compared, together with age- and IQ-matched 
control subjects showed deficit in a range of cognitive skills, including pattern 
recognition, planning and ability to shift attention from one frame of reference to 
another. This study suggested chronic drug use may lead to distinct patterns of cognitive 
impairment that may be associated with dysfunction of different components of cortico-
striatal circuitry. Additionally, Ersche and colleague (2006) found that chronic drug 
users display neuropsychological impairment in executing function and memory also, 
if the impairment persist after several years, it may reflect neuropathology in frontal 
and temporal cortices.  
The chronic effects of prolonged substance abuse may differ between opiate and 
amphetamine supported by a study of examination of post-mortem of brain indicate 
amphetamine users qualitatively obtain more severe neuropathology compared to 
opiate users (Kish et al., 2001). Even though there are neuropathology studies regarding 
effect of amphetamine and opioid users respectively, neuropsychological studies that 
directly compare the cognitive performance in both amphetamine and opiate users are 
still sparse (Ersche et al., 2006).  
1.8 Problem Statement 
Having stimulant and hallucinergic effects, ATS has a wide range of physical 
and psychological health impact. Long term of the use of both substances may lead to 
various cognitive impairments. Dependence on opioid and ATS frequently co-occur, 
and many studies showed that cognitive impairment as a result of using this drug 
(Pilowsky, 2011).  
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However, studies about cognitive function for drug user that use both drugs are 
scarce. Based on the study done by Dalleys et al. (2005), they found that most 
amphetamine users have deficit in cognitive especially in their attention. Other than 
that, one of the studies done by Hekmat et al. (2010) found that the addicted subject in 
performing heroin is worse in executive function measures such as speed of mental 
processing measured by digit symbol test. The trend of using this both drugs together 
are keep increasing, thus the cognitive measure may provide a clear picture and will aid 
in treatment programs for drug users. 
Kelantan was experiencing serious problem with opioid, ATS and HIV 
compared to other state of Malaysia. The number of ATS-related arrests in Kelantan 
increased 5051 substantially from 2,900 in 2007 to 5,300 in 2010 and 9,413 in 2012 
(Royal Malaysian Police 2013).  According to AADK report, the statistic of a new drug 
users in Kelantan was increased from 1019 (7.49%) in 2014 to 1683 (8.30%) in 2015 
(AADK, 2014, 2015). Besides, there was also increased in registered new drug users 
from 29 269 in 2014 to 31 257 in 2015 based on AADK current report. 
     
Co-occurring ATS and Opioid are quite concerning in Kelantan. Both types of 
drugs are highly addictive, and it overlapping effect on brain reward system and 
circulatory that regulating motivation, emotional and executive function including 
impulse control (Ersche & Sahakian 2007; Trujillo, Smith & Guaderrama 2011). Other 
than that, the person that using both drug (ATS and Opioids) usually having high level 
of psychiatric co-morbidity and require more intensive clinical management (Pilowsky 
et al. 2011).      
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1.9 Objectives of the Study 
To evaluate the scope and the specific patterns of deficits in cognitive and 
neuropsychological functioning among opiate and ATS (Dual Drug Dependence 
(DDD)) abusing individuals enrolled in a medication-assisted treatment in Hospital 
Universiti Sains Malaysia (HUSM) with a healthy control group in Kelantan. Cognitive 
functions evaluated were: 
1. Visuo-constructional, visuo-perceptual ability, incidental visual memory and 
attention - Rey-Osterrieth Complex Figure (ROCF). 
2. Perceptual Motor Speed, Visual Scanning and Cognitive Flexibility - Trail 
Making Test Part A and B 
3. Reasoning Skills - Raven’s Progressive Matrices. 
4. Short-term Memory and Working Memory - Digit Span Test Forward and 
Backward (DST). 
5. Speed of Mental Processing - Symbol Digit Test (SDT). 
6. Response Inhibition - Stroop test. 
1.10 Hypotheses 
1. H0 - There is no significant mean difference in visuo-constructional, visuo-
perceptual ability, incidental visual memory and attention between Dual Drug 
Dependence (DDD) patients and control group measured by Rey-Osterrieth 
Complex Figure (ROCF). 
H1–There is a significant mean difference in visuo-constructional, visuo-
perceptual ability, incidental visual memory and attention between (DDD) 
patients and control group measured by Rey-Osterrieth Complex Figure 
(ROCF). 
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2. H0 - There is no significant mean difference in Perceptual Motor Speed, Visual 
Scanning and Cognitive Flexibility between DDD patients and control group 
measured by Trail Making Test Part A and B. 
H1 – There is a significant mean difference in Perceptual Motor Speed, Visual 
Scanning and Cognitive Flexibility between DDD patients and control group 
measured by Trail Making Test Part A and B. 
 
3. H0 - There is no significant mean difference in reasoning skills, between DDD 
patients and control group measured by Raven’s Progressive Matrices. 
H1 - There is a significant mean difference in reasoning skills, between DDD 
patients and control group measured by Raven’s Progressive Matrices. 
 
4. H0 - There is no significant mean difference in short-term memory and working 
memory between DDD patients and control group measured by Digit Span Test 
Forward and Backward (DST). 
H1 - There are significant mean differences in short-term memory and working 
memory between DDD patients and control group measured by Digit Span Test 
Forward and Backward (DST). 
 
5. H0 - There is no significant mean difference in speed of mental processing 
between DDD patients and control group measured by Symbol Digit Test 
(SDT). 
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H1 - There are significant mean differences in speed of mental processing 
between DDD patients and control group measured by Symbol Digit Test 
(SDT). 
 
6. H0 - There is no significant mean difference in response inhibition between 
DDD patients and control group measured by Stroop test. 
H1 - There are significant mean differences in response inhibition between DDD 
patients and control group measured by Stroop test. 
1.11 Significance of the Study 
 This study is about cognitive and neuropsychological functioning of opioid and 
ATS use and it provides cognitive profile (executive functions) with the emphasis on 
visuo-perceptual, visuo-constructional ability, incidental visual memory, attention, 
perceptual motor speed, visual scanning, cognitive flexibility, reasoning skills, short 
term memory, working memory, speed of mental processing and response inhibition. 
This study is expected to provide an insight about possible cognitive impairments 
related to the use of both drugs since this is the first known study to measure cognitive 
function among drug addicts that use both drugs in Malaysia. Besides, this study also 
provides data on cognitive function of heroin and ATS users. 
It is important in considering the present cognitive function when treating 
patient with addiction. This could enable clinicians to help patients to master adaptive 
strategies in overcoming patient relapse when patient return to the environments related 
with their prior use of drug. Besides, cognitive deficit may hinder patient’s ability to 
maximize benefits from counseling session and other psycho-social treatments in aiding 
the patient to stay abstinent from drug use by learning or incorporating sustaining 
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strategies in their daily routine (Gould, 2010). Evidence showed that cognitive 
impairment in drug use has negative impact especially in treatment engagement (Ersche 
& Sahakian, 2007). 
1.12 Scope of the Study 
This study was carried out in Kelantan (Kota Bharu) because heroin and ATS 
dependence are highly prevalent and frequently co-occur (Singh et al., 2013). This 
region has high concentrated amount of individuals who use drugs and the trend of 
using both drugs is increasing. Also, Kelantan has the highest number of HIV case in 
Malaysia (Utusan Malaysia, 2015).  The study focus on cognitive function that may 
impair DDD patients by using selected neuropsychological test. 
Neuropsychological tests are used to study a range of cognitive skills in 
different areas. Neuropsychological testing is a crucial part of assessment and treatment 
of patients especially patients with brain problem and it is also beneficial to investigate 
substance use effects on brain functioning (Barry & Carson-DeWitt, 2005). This test is 
used for screening to know if diagnostic assessments are needed or not. 
Six neuropsychological test was used in this study to the COATS patient and 
control healthy group. For the population, this study focus on two group, which are 
DDD patient who dependence on ATS and Opioid and one control healthy group. This 
study was conducted to determine the cognitive status of COATS patient and 
comparing with control group. COATS patient that was recruited in this study was from 
medication assisted treatment (treatment that combine medication and psychological 
aspect) in HUSM. The aspects looked into were the neurocognitive functioning among 
COATS patient. For the control group, the test was similar used by COATS patients 
and also the place of assessment also the same. The problem was identified to provide 
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better treatment by recognizing their impairment comparing with the normal control 
group who did not use any illegal drug and identifying the proposed solution to the 
problem. The location of the study was at HUSM.  
1.13 Study Limitations 
There were some unavoidable limitations. For this study, it was conducted in 
only one state in Malaysia (Kelantan), and thus should not be generalized to the whole 
issue of drug use in the country. It was important to do this study in every part of 
Malaysia to see the clear picture on drug addiction cognitive profiles crucially. Thus, 
in the future, these types of study can be done in every part of the state in Malaysia with 
the convenient drug detoxification facility to address their cognitive deficit.  
Other limitation was the number of COATS patient was small. In order to get 
better result higher number of patient are required. The problem encountered was, the 
COATS patients was a hidden population, hard to get reach to their area. But with the 
amount of COATS patient we get are enough to run the analysis. In future, getting more 
participant may give concrete result. Nevertheless, for the control group, easy to get the 
involved in this study because easy recruiting them because they was not a hidden 
population. 
1.14 Definition of Terms 
1.14.1 Opioid 
Opioid are mainly used to relieve pain. It will reduce the intensity of the pain when 
the signal of pain reaching the brain and it will diminished the painful effects stimulus (NIDA, 
2014). Opioids are chemically interacted with opioid receptors in the nerve cells especially in 
the body and brain. Misuse of opioid may lead to euphoria instead of pain relievers. Misuse of 
opioid also can lead to drug dependence and fatal if overdose (NIDA, 2014).   
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1.14.2 Amphetamine-Type Stimulants 
Amphetamine-type stimulants (ATS) refer to a group of drugs whose 
principal members include amphetamine and methamphetamine. However, a 
range of other substances also fall into this group, such as methcathinone, 
fenetylline, ephedrine, pseudoephedrine, methylphenidate and MDMA or 
‘Ecstasy’ – an amphetamine-type derivative with hallucinogenic properties 
(WHO, 2016). 
1.14.3 Co-Occurring Opioid and ATS 
Co-occurring define as a ‘to appear together’. In this context, co-occurring 
refer to person that take both opioid and ATS simultaneously to get pleasurable 
effect. The use of this both drug will increased the pleasurable effect uniquely 
such as reduce anxiety, that was experienced by ATS or reduces sedation which 
experienced by opioid, compared if using it alone (Leri, Bruneau & Stewart 2003; 
Trujillo, Smith & Guaderrama 2011).   
 
        1.14.4 Cognitive Psychology  
This is one of the branches of the psychology that concerned with mental 
processes such as thinking, learning, perception and memory especially with 
the internal event that happen between the sensory stimulation and overt 
expression of behavior (Merriam-Webster, 2016). The cognitive 
psychology will look into how our mental processing information will 
influences the behavior.   
 
1.14.5 Neuropsychological Assessment 
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Neuropsychological assessment is a performance-based method to 
assess cognitive functioning. This method is used to examine the cognitive 
consequences of brain damage, brain disease, and severe mental illness (Harvey, 
2012).  Typically, neuropsychological assessment is performed with a battery 
approach, which involves tests of a variety of cognitive ability areas, with more 
than one test per ability area. These ability areas include skills such as memory, 
attention, processing speed, reasoning, judgment, and problem-solving, spatial, 
and language functions. 
1.14.6 Memory 
Memory is essential to all our lives. Memory is commonly described as 
the process of maintaining information over time (Matlin, 2005). Without a 
memory of the past we cannot operate in the present or think about the 
future.  We would not be able to remember what we did yesterday, what we 
have done today or what we plan to do tomorrow.  Without memory we could 
not learn anything (Mcleod, 2007). Memory is when one’s draw the past 
experience in order to use the information at present (Sternberg, 1999). 
1.14.7 Attention 
Attention is the concentration of awareness on some phenomenon to the 
exclusion of other stimuli. Attention is the behavioral and cognitive process of 
selectively concentrating on a discrete aspect of information, whether deemed 
subjective or objective, while ignoring other perceivable information (Anderson 
& John, 2004). 
 
 
1.14.8 Visual Scanning 
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Visual Scanning is the ability to actively find relevant information in our 
surroundings quickly and efficiently (Cognifit, 2016). Examples of visual 
scanning are spotting certain person in a crowded place such as at the party or 
the other example was finding a specific location in a map. Slow speed and the 
accuracy of the reaction and responses may indicate lack of visual scanning. 
Example when driving, lack of visual scanning may cause an accident and 
dangerous. 
1.14.9 Mental Processing Speed 
Mental processing speeds refer to ability to solve easy task in the 
restricted amount of time (Doebler & Holling, 2015). Processing Speed is one 
of the measures of cognitive efficiency or cognitive proficiency.  It involves the 
ability to automatically and fluently perform relatively easy or over-learned 
cognitive tasks, especially when high mental efficiency is required.   
1.14.10 Working Memory 
Working memory refers to a brain system that provides temporary 
storage and manipulation of the information necessary for such complex 
cognitive tasks as language comprehension, learning, and reasoning (Baddeley, 
1992). Often known as short-term memory, working memory is just like a brain 
task. As the information coming into the brain, it will process and 
simultaneously, storing it. It is important to learn, reasoning, and remember. 
Example when doing a mathematical, one’s have to store the number temporary 
while at the same time they have to solve the problem. In general, keeping the 
information temporarily and process it at the same time is a working memory 
(Psychology Glossary, 1998). 
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CHAPTER 2 
LITERATURE REVIEW 
2.0 Introduction 
 In this chapter, theories and past studies that are relevant to the focus of the 
present study are described and reviewed. The conceptual and theoretical frameworks 
for the study are also explained.  
2.1 Drug Addiction 
The word drug was originality from a French word “drogue” which means “a 
dry substance” and during that time, the dried herbs were widely used to prepare most 
of the pharmaceuticals (Abadinsky, 2010).  
Drug addiction is a chronic, often relapsing brain disease that causes 
compulsive drug seeking and use, despite harmful consequences to the drug addict and 
those around them. Drug addiction is a brain disease because the abuse of drugs leads 
to changes in the structure and function of the brain. Drugs are chemicals that tap into 
the brain's communication system and disrupt the way nerve cells normally send, 
receive, and process information. There are at least two ways that drugs are able to do 
this: by imitating the brain's natural chemical messengers, and/or over stimulating the 
"reward circuit" of the brain. In 2014, the Malaysian National Anti-Drug Agency 
(NADA) reported that there were 387,144 individuals registered as using drugs; 
however, the true number of individuals using illicit psychoactive substances is likely 
to be higher. Based on the NADA statistics, opioid use continues to dominate among 
newly registered drug using individuals, with ~67% registered as using opioids and 
~20% registered as using ATS (NADA 2015). Most individuals using opioids inject the 
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drug; 25-30% of people who inject drugs (PWID) are infected with HIV; and injection 
drug use accounts for 70% of HIV infections in Malaysia (101,672 registered HIV+ 
between 1986 and 2013).  
Co-occurring ATS use among people who use opioids has also emerged as a 
major problem in Malaysia. In recent surveys of people who inject heroin or other 
opioids, 75% reported lifetime ATS use (and 21% reported injecting ATS), and lifetime 
ATS use was significantly associated with HIV infection (Chawarski et al. 2012). Some 
additional recently reported trends include rising rates of individuals under the age of 
20 using drugs (NADA 2015; Hamudin 2015), growing attention on women who use 
drugs (Mohd Nasarrudin et al. 2015; Rahman et al. 2015; Wickersham et al. 2016), and 
continued research focus on relationships between substance use and infectious 
diseases, particularly HIV and Hepatitis C (Bachireddy et al. 2011; Choo et al. 2015).  
Addiction is associated with impairments in prefrontal cortex (PFC) dependent 
cognitive functions; it is thought that these impairments promote compulsive drug use 
and relapse (Volkow & Fowler, 2000). Opiate addicts and psychostimulant addicts 
share some deficits in memory, cognitive flexibility and decision making (Bechara, 
2005). Studies using laboratory animals have shown that repeated exposure to cocaine 
or heroin impairs spatial memory (Tramullas, 2008). There are some fundamental 
differences between opiates and psychostimulants. For example, cocaine and 
amphetamine addicts are more impulsive and show more pronounced deficits in 
attention and cognitive flexibility than heroin addicts (Lundqvist, 2005). 
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2.2 Opioid 
Opioids act by attaching to specific proteins called opioid receptors, which are 
found in the brain, spinal cord, gastrointestinal tract, and other organs in the body. 
When these drugs attach to their receptors, they reduce the perception of pain. Opioids 
can also produce drowsiness, mental confusion, nausea, constipation, and, depending 
upon the amount of drug taken, can depress respiration. Some people experience a 
euphoric response to opioid medications, since these drugs also affect the brain regions 
involved in reward. Heroin addiction is defined as a chronic relapsing condition that, 
for many, is an unrelenting, lifelong illness with severe effects. This is particularly 
relative to short life expectancies and high rates of morbidity Hser et al. (2004). Ninety 
percent of the world’s heroin supply is directly from opium grown in Afghanistan. 
Heroin that is produced from Afghan poppies is shipped worldwide (UNODC, 2010).  
2.3 Amphetamine Type Stimulants 
 ATS or commonly known as ‘Ya Ba’ (crazy medicine) in Thailand and ‘pil 
kuda’ or buah (street name) in Malaysia. Yaba is a combination of methamphetamine 
(a powerfuland addictive stimulant) and caffeine. Yaba, which means crazy medicine 
in Thai, is produced in Southeast and East Asia. The drug is popular in Asian 
communities in the United States and increasingly is available at raves and techno 
parties. Yaba is sold as tablets. These tablets are generally no larger than a pencil eraser. 
They are brightly colored, usually reddish-orange or green. Yaba tablets typically bear 
one of a variety of logos; R and WY are common logos. Yaba tablets typically are 
consumed orally. The tablets sometimes are flavored like candy (grape, orange, or 
vanilla). Another common method is called chasing the dragon. Users place the yaba 
tablet on aluminum foil and heat it from below. As the tablet melts, vapors rise and are 
 
 
22 
 
inhaled. The drug also may be administered by crushing the tablets into powder, which 
is then snorted or mixed with a solvent and injected. 
ATS or psycho-stimulants will cause an individual who taking it to feeling 
euphoria, alertness, increased concentration and motor activity. They will increase 
blood pressure and pulse rate and the long term use may cause effect such as violent 
and irrational behavior and psychosis (Camí & Farré, 2003; Paci, 2008). Amphetamine 
was derived from methamphetamine which have high lipid solubility comparing with 
amphetamine and produce more intense effects on central nervous system (Barr et al., 
2006). In acute phase, amphetamine inhibit reuptake of dopamine, norepinephrine and 
serotonin from membrane transporters and it will increase the level of these 
neurotransmitter in the brain. This will give decrease of dopamine transporter which 
associated with impaired neuropsychological functioning (Camí & Farré, 2003: Logan, 
2002; Nordahl, Salo & Leamon, 2003; Scott et al., 2007). 
2.4 Co-occurring Opioid and ATS Use 
Co-occurring opioid and ATS use in Malaysia and Kelantan is increasing 
although pharmacological  effect on opioid and ATS in human body and brain are 
different (Koob & Bloom 1988), the combination of an opioid and a psychostimulant 
(e.g., amphetamine, methamphetamine, or cocaine) is also known as a “speedball. The 
combination between Opioids and ATS may lead to addiction with overlapping effects 
in reward circuitary system in the brain that is important for regulation of executive 
function, motivation, affective or emotional response (Ersche & Sahakian 2007; 
Trujillo, Smith & Guaderrama 2011). People who use this combination of drug report 
that, it produces increased or unique pleasurable effects compared if taking a drug alone 
or reduces the adverse effects of one of the drugs (e.g., reduces anxiety experienced 
